Newsroom | IDEAYA Biosciences https://media.ideayabio.com/ IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants https://media.ideayabio.com/2026-06-08-IDEAYA-Announces-Pricing-of-300-Million-Offering-of-Common-Stock-and-Pre-Funded-Warrants Mon, 08 Jun 2026 22:22:00 -0400 https://media.ideayabio.com/2026-06-08-IDEAYA-Announces-Pricing-of-300-Million-Offering-of-Common-Stock-and-Pre-Funded-Warrants IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://media.ideayabio.com/2026-06-08-IDEAYA-Announces-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants Mon, 08 Jun 2026 16:01:00 -0400 https://media.ideayabio.com/2026-06-08-IDEAYA-Announces-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants IDEAYA Biosciences Announces Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer https://media.ideayabio.com/2026-06-03-IDEAYA-Biosciences-Announces-Clinical-Collaboration-with-Roche-in-MTAP-Deleted-RAS-Mutant-Pancreatic-Cancer Wed, 03 Jun 2026 06:00:00 -0400 https://media.ideayabio.com/2026-06-03-IDEAYA-Biosciences-Announces-Clinical-Collaboration-with-Roche-in-MTAP-Deleted-RAS-Mutant-Pancreatic-Cancer IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Late-Breaking Oral Presentation at ASCO https://media.ideayabio.com/2026-06-01-IDEAYA-Biosciences-and-Servier-Provide-Complete-Data-from-Phase-2-3-Registrational-OptimUM-02-Trial-of-the-Darovasertib-Combination-in-First-Line-HLA-A2-01-Negative-Metastatic-Uveal-Melanoma-in-a-Late-Breaking-Oral-Presentation-at-ASCO Mon, 01 Jun 2026 11:00:00 -0400 https://media.ideayabio.com/2026-06-01-IDEAYA-Biosciences-and-Servier-Provide-Complete-Data-from-Phase-2-3-Registrational-OptimUM-02-Trial-of-the-Darovasertib-Combination-in-First-Line-HLA-A2-01-Negative-Metastatic-Uveal-Melanoma-in-a-Late-Breaking-Oral-Presentation-at-ASCO IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://media.ideayabio.com/2026-05-29-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4 Fri, 29 May 2026 06:00:00 -0400 https://media.ideayabio.com/2026-05-29-IDEAYA-Biosciences-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4